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Esophageal cancer is the sixth most common cause of cancer-related deaths with an estimated 455,800 new cases and 400,200 deaths in 2012 worldwide. 1 The overall 5-year survival of patients with esophageal cancer ranges from 15% to 25%. 2 Esophageal squamous cell carcinoma (ESCC) is one of the fatal diseases because of the rapid progression and the lack of early detection. ESCC is characterized by early lymphatic metastasis, which is the main cause of the poor prognosis in patients with this malignancy. 3 Even in superficial esophageal cancers invading no further than the submucosa, 30%-40% of the cases have regional lymph node metastasis. 4 Tobacco use and alcohol consumption are known to contribute to a high risk of ESCC and genetic polymorphisms including ALDH2, CCND1, PTEN and PD-L1 have been identified as risks for ESCC. [5] [6] [7] [8] Tumor microenvironments are composed of non-tumor cells and their stroma such as fibroblasts, vascular cells, glial cells, smooth muscle cells, endothelial cells, fat cells and cells of the immune system. Macrophages are the most abundant cancer stromal cells involved in the host immune system. Macrophages have two different phenotypes; classically activated macrophage (M1) and alternatively activated macrophage (M2). M1 macrophages are induced by interferon-gamma (IFN-g), whereas M2 macrophages are induced by interleukin (IL)-4 and IL-13. 9 Tumor-associated macrophages (TAMs) have differentiated into the M2 phenotype and contribute to the progression of disease. The protein CD163 and CD204 have been used as markers of M2 macrophages. 10, 11 TAMs induce angiogenesis in the tumor microenvironment, suppress antitumor immunity and directly stimulate tumor cell proliferation. TAMs also participate in the formation of a cancer stem cell niche and pre-metastatic niche to promote tumor progression. 12 We demonstrated an association between an increased number of infiltrating CD204
þ TAMs and the poor prognosis of ESCCs. 13 CD204 þ TAMs have been reported to correlate with poor prognosis in many cancers, including lung cancer, bladder cancer, breast cancer, ovarian cancer and uterine cervical adenocarcinoma. [14] [15] [16] [17] [18] However, the pathological mechanisms of TAMs on the tumor microenvironment of ESCC remain unclear. In the present study, we established a coculture assay using human ESCC cell lines and TAMlike peripheral blood monocyte (PBMo)-derived macrophages to investigate the pathological roles of TAMs in ESCC. We further investigated the cancer-associated gene expression profile in ESCC cell lines co-cultured with TAM-like PBMo-derived macrophages by a cDNA microarray analysis.
MATERIALS AND METHODS

Cell lines and cell culture
Three human ESCC cell lines (TE-8, TE-9 and TE-15) were obtained from the RIKEN BioResource Center (Tsukuba, Japan). A short tandem repeat analysis of TE series ESCC cell lines was conducted at RIKEN and the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). We routinely propagated and prepared the conditioned media of TE series ESCC cell lines (TECM) as described elsewhere.
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Co-culture assay
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy volunteer donors who provided informed consent. Purification of CD14 þ PBMo from the PBMCs, macrophage differentiation and induction of TAM-like polarization were performed as previously described. 19 A coculture assay was established using ESCC cells (TE-8 and TE-9) in 6-well plate and TAM-like PBMo-derived macrophages in 0.4 mm pore membrane insert (BD Falcon, Lincoln Park, NY, USA). The ESCC cells were plated on the bottom chamber at 2.0 Â 10 5 cells/well in serum-free medium 1 day prior to co-culture assay. We washed TAM-like PBMo-derived macrophages in inserts three times with serum-free medium and co-cultured with ESCC cells in serum-free condition for 2 days.
Cell proliferation assay
The TE cells were seeded in 24 plates at 1.0 Â 10 4 /well with serum-free medium and incubated at 37°C in 5% CO 2 . After 24or 48 h, CellTiter 96 Aqueous One Solution Reagent (Promega, Madison, WI, USA) was added to each well. The absorbance at 492 nm measured using an Infinite 200 PRO microplate reader (Tecan, Mannedorf, Switzerland).
cDNA microarray analysis
Total RNA was extracted from two monocultured and cocultured ESCC cell lines (TE-8 and TE-9) with TAM-like PBMo-derived macrophages using the RNeasy kit (Qiagen, Hilden, Germany). A cDNA microarray was performed using the GeneChip Human Gene 2.0 ST Array (Affymetrix, Santa Clara, CA, USA), containing 53617 probes characterized human genes and expressed sequence tags. A company (Filgen, Nagoya, Japan) conducted the DNA microarray analysis. We deposited the data to the Gene Expression Omnibus database (GSE118642).
Quantitative reverse transcription-PCR (qRT-PCR) and RT-PCR
Quantitative RT-PCR amplifications of CYP1A1, DHRS3, ANXA10, KLK6, CYP1B1, AMTN, IGFL1 and the control gene GAPDH were conducted using the ABI Step One Real-time PCR system (Applied Biosystems, Foster City, CA, USA). The primers for those genes were from TaqMan Gene Expression Assays (Applied Biosystems). The primers were as follows: 
Western blotting
Cells were lysed in cell lysis buffer (50 mM Tris-HCl pH 7.5, 125 mM NaCl, 5 mM EDTA and 0.1% Triton X-100) containing both 1% protease inhibitor and 1% phosphatase inhibitor cocktail (Sigma-Aldrich, St Louis, MO, USA). Equal amounts of protein were separated on 10% SDS-PAGE and then transferred to polyvinylidene fluoride membranes with an iBlot 1 2 Gel Transfer Stack (Thermo Fisher Scientific).
The membranes were incubated with primary antibodies at 4°C overnight. The primary rabbit antibodies used were anti-ANXA10 antibody (1:500, NBP1-90156SS, Novus Biologicals), anti-phosphorylated Akt (Ser473) (/1:500, #4060, Cell Signaling Technology, Beverly, MA), anti-phosphorylated Akt (Thr308) (1:500, #2965, Cell Signaling), anti-Akt (1:1000, #9272, Cell Signaling), anti-phosphorylated Erk1/2 antibody (Thr202/Tyr204) (1:500, #9101, Cell Signaling), anti-Erk1/2 antibody (1:1000, #9102, Cell Signaling), anti-bactin antibody (1:1000, #4970, Cell Signaling). The membranes were then probed with secondary antibodies for 90 min at room temperature. The secondary antibody was horseradish peroxidase-conjugated donkey anti-rabbit IgG (1:1000, NA934V, GE Healthcare, Little Chalfont, Buckinghamshire, UK).
Cell transfection
Cells of the ESCC lines TE-8 and TE-9 were transfected with 20nM small interfering RNA (siRNA) targeting human ANXA10 (sc-72503, Santa Cruz) and negative control siRNA (Sigma-Aldrich) for 2 days. We used plasmid DNA that encoded ANXA10 and Myc-DDK-tagged ORF clone ANXA10 (NM_007193, OriGene Technologies, Rockville, MD) as transfection ready DNA for overexpressing ANXA10 in the ESCC cell line TE-15. The plasmid DNA were transfected into TE-15 cells using Lipofectamine 1 3000 reagent (Thermo Fisher Scientific).
After gene transfection 2 days, the complete medium containing 300mg/mL Geneticin Thermo Fisher Scientific 
RESULTS
Up-regulated and down-regulated genes in TE-8 and TE-9 ESCC cells co-cultured with TAM-like PBModerived macrophages
We first constructed an in vitro system of PBMo-derived macrophages for their differentiation into TAM-like PBModerived macrophages. We then used a co-culture assay Figure 1 Co-culture assay of ESCC cells with TAM-like PBMo-derived macrophages. (a) Experiment outline of the co-culture assay of the two ESCC cell lines (TE-8, TE-9) with TAM-like PBMo-derived macrophages. CD14 þ PBMo were cultured at 1.0 Â 10 5 cells/insert with 25 ng/mL M-CSF for 6 days to induce macrophages. We exchanged with 50% TECM (TE-8 or TE-9) in inserts to induce TAM-like PBModerived macrophages. TE-8 and TE-9 ESCC cells were seeded on the bottom chamber of 6-well plates at 2.0 Â 10 5 cells/well in serum-free medium 1 day prior to co-culture assay. We washed TAM-like PBMo-derived macrophages in inserts three times with serum-free medium and co-cultured with ESCC cells in serum-free condition for 2 days. (b) The cell growth activity was increased in both ESCC cell lines (TE-8, TE-9) co-cultured with TAM-like PBMo-derived macrophages compared to the monocultured ESCC cell lines. Cells were seeded on 24-well plates at 1.0 Â 10 4 cells/well in serum-free RPMI-1640 with monocultured or co-cultured ESCC cell lines. After 48 hours, the cell growth activities were determined by an MTS assay.
with TAM-like PBMo-derived macrophages and ESCC cell lines to study the effects of TAMs on the ESCC tumor microenvironment (Fig. 1a) . We observed increased cell growth in TE-8 and TE-9 ESCC cells co-cultured with TAMlike PBMo-derived macrophages compared to the growth of monocultured cancer cells (Fig. 1b) .
We subsequently performed a cDNA microarray analysis using total RNAs from the TE-8 and TE-9 ESCC cells monocultured and co-cultured with TAM-like PBMo-derived macrophages. We identified 316 up-regulated (ratio ! 2.0) and 293 down-regulated (ratio 0.5) genes in TE-8 cells and 619 up-regulated and 520 down-regulated genes in TE-9 cells (Table S1 ). We focused on commonly up-regulated (CYP1A1, DHRS3, ANXA10, KLK6 and CYP1B1) and downregulated (AMTN and IGFL1) genes in both co-cultured ESCC cell lines ( Table 1 ). The results of the cDNA microarray analysis were confirmed by qRT-PCR (Fig. 2a-g ).
The expression levels of ANXA10 were closely correlated with clinical-pathological features and the prognosis of the ESCC patients
To check the clinical-pathological features of the up-regulated genes extracted by the cDNA microarray analysis, we performed immunohistochemistry of ANXA10, KLK6 and CYP1B1 whose specific antibodies were available on 68 cases of ESCC tissues (Figs. 3a, S1 , S2 and Tables S2,  S3 ). Among the three molecules, the expression levels of ANXA10 in cancer cells were significantly correlated with the depth of invasion (P ¼ 0.031) in the ESCC patients ( Table 2 ). We also observed that a high number of infiltrating CD68 þ (P ¼ 0.046) or CD204 þ (P ¼ 0.006) macrophages was significantly correlated with high expressions of ANXA10 in cancer cells ( Table 2 ). The disease-free survival of the patients with a high expression of ANXA10 was significantly shorter compared to that of the patients with low ANXA10 by log-rank test (P ¼ 0.0216) (Fig. 3b) . The overall survival of the patients and cancer-related survival was not significantly different between the low and high ANXA10 expression groups (Fig. 3b) .
ANXA10 knockdown suppressed the growth of TE-8 and TE-9 ESCC cells by inhibiting Akt and Erk1/2 phosphorylation
The up-regulations of ANXA10 mRNA (Fig. 4a) and protein ( Fig. 4b) were confirmed in TE-8 and TE-9 cells co-cultured with TAM-like PBMo-derived macrophages compared to the monocultured cells by both RT-PCR and western blotting. We then attempted to knockdown ANXA10 in TE-8 and TE-9 cells to determine the biological significance of ANXA10 in the growth of ESCC cells. The levels of ANXA10 mRNA and protein were significantly decreased in siRNA-transfected TE-8 and TE-9 cells (Fig. 4c, d , f). ANXA10 knockdown significantly inhibited the growth of both of these ESCC cell lines (Fig. 4e) . ANXA10 knockdown suppressed the phosphorylation status of p-Akt (Ser473 and Thr308) and p-Erk1/2 (Thr202/Tyr204) and inhibit the growth of the ESCC cell lines (Fig. 4f) .
Overexpression of ANXA10 induced the growth of TE-15 cells by triggering Akt and Erk1/2 phosphorylation
TE-15 cells demonstrated lower ANXA10 mRNA and protein expression compared to the TE-8 and TE-9 cells (Fig. 5a, b) . To examine the effect of ANXA10 overexpression, we introduced ANXA10 expression vector into TE-15 cells. We confirmed that the ANXA10 mRNA and protein expressions were increased in transfected TE-15 cells (Fig. 5c, d , f). ANXA10 overexpression significantly induced cell growth of TE-15 cells (Fig. 5e ). ANXA10 overexpression increased the phosphorylation status of p-Akt (Ser473 and Thr308) and p-Erk1/2 (Thr202/Tyr204) and increased the growth induction of the ESCC cells (Fig. 5f ).
DISCUSSION
Our prior study demonstrated that PBMo-derived macrophages stimulated with TECM acquire M2-like characteristics and up-regulated GDF15 and CXCL8 expression. 19, 22 GDF15 and CXCL8 are associated with CD204 þ macrophage infiltration in human ESCC and it promoted the growth of ESCC cells via the phosphorylation of Akt and Erk1/2.
19,22
TAMs have been reported to promote tumor progression in pancreatic cancer, breast cancer and hepatocellular carcinoma by a cancer cell-macrophage co-culture system. [23] [24] [25] In the present study, we newly established a co-culture system with human ESCC cell lines and TAM-like PBModerived macrophages to investigate the biological effects of Figure 2 The mRNA levels of up-regulated or down-regulated genes in ESCC cell lines monocultured and co-cultured with TAM-like PBMo-derived macrophages by quantitative RT-PCR. (a-e) The mRNA levels of CYP1A1, DHRS3, ANXA10, KLK6 and CYP1B1 were upregulated and (f, g) AMTN and IGFL1 were down-regulated in co-cultured TE-8 and TE-9 cells compared to the respective monocultured ESCC cell lines. GAPDH was used as a control. Data are mean AE SEM in triplicate. ÃÃ P < 0.01, Student's t-test. TAMs on ESCC cells. We observed an increased proliferation of ESCC cells co-cultured with TAM-like PBMo-derived macrophages compared to the proliferation of monocultured cancer cells. We then extracted up-regulated and downregulated genes in ESCC cells co-cultured with TAM-like PBMo-derived macrophages in a comparison with monocultured cancer cells by cDNA microarray analysis. We focused on KLK6, CYP1B1 and ANXA10 among the up-regulated genes.
KLK6 belongs to a large family of Kallikrein-related peptidases that secrete serine proteases and are aberrantly expressed in many cancers. 26 KLK6 is correlated with tumor progression in gastric cancer, ovarian cancer and melanoma. [27] [28] [29] However, the roles of KLK6 in ESCCs have not been elucidated. Our present findings revealed that high expression levels of KLK6 were negatively correlated with the number of infiltrating CD68 -test. P < 0.05 was considered statistically significant: Ã P < 0.05, ÃÃ P < 0.01. ‡ According to the Japanese Classification of Esophageal Cancer. HGIEN, high-grade intraepithelial neoplasia; WDSCC, well-differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma. T1, tumor invades mucosa and submucosa; T2, tumor invades muscularis propria; T3, tumor invades adventitia. in ESCCs. We also observed that a high expression of KLK6 was not correlated with the poor prognosis of ESCC patients. CYP1B1 is a recently cloned dioxin-inducible form of the cytochrome P450 family of xenobiotic metabolizing enzymes. 30 Recent studies reported that polymorphism of CYP1B1 which plays a role in the metabolism of xenobiotics was not associated with ESCC risk. 31, 32 Our present clinical-pathological findings suggest that a high expression of CYP1B1 is associated with the depth of invasion and disease-free survival but not with infiltrated the number of infiltrated TAMs. and traditional serrated adenomas compared to normal colonic epithelia, hyperplastic polyps, tubulovillous adenomas and tubular adenomas. 37, 38 Regarding ANXA10 and cancer, ANXA10 was first reported on hepatocellular carcinoma (HCC), as chromosome 4q is one of the most common chromosomal regions with a high frequency of allelic loss in HCC. In HCC, down-regulation of ANXA10 is correlated with vascular invasion, early recurrence and poor prognosis. 39 A correlation of ANXA10 down-regulation and poor prognosis has also been reported in gastric cancer, bladder cancer and prostate cancer. [40] [41] [42] [43] On the other hand, it was reported that ANXA10 overexpression was correlated with a poor prognosis and associated with poor prognostic molecular features such as CIMP and the BRAF mutation in colorectal carcinomas. 44 ANXA10 was significantly overexpressed in pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm and pancreatic adenocarcinoma and the co-expression of ANXA10 and CD24 was associated with disease progression, while ANXA10 was not expressed in normal pancreatic epithelia. 45 In oral squamous cell carcinoma (OSCC), it was reported that ANXA10 overexpression was associated with tumoral progression. 46 In esophageal cancer, it was reported that compared to normal squamous esophagus epithelium, ANXA10 was highly expressed in esophageal adenocarcinoma and squamous cell carcinoma. 47 However, the expression of ANXA10 in ESCC tissues and its correlation to clinicalpathological features have not been elucidated. Our present analysis demonstrated that a high expression of ANXA10 in ESCC cells was significantly correlated with the depth of invasion, high numbers of infiltrating CD68 þ and CD204 þ TAMs and poor disease-free survival. This strongly implies that ANXA10 plays an important role in the progression of ESCCs. Our present findings also indicate the possibility that ANXA10 expression in cancer cells is provoked by an interaction with TAMs in the ESCC microenvironment. It has been reported that the silencing of ANXA10 resulted in decreased cellular proliferation by the inactivation of ERK in OSCC. 46 ANXA10 might affect intracellular Ca 2þ homeostasis and directly or indirectly interact with the activation of MEK/ERK signaling pathways. 46 To determine whether ANXA10 function is relevant to ESCC progression, we performed functional studies using siRNA. The results showed that ANXA10 knockdown significantly decreased cell growth by inhibiting Akt and Erk1/2 signaling pathways. We also introduced ANXA10 expression vector into ESCC cells with a low expression of ANXA10 and we observed that ANXA10 significantly increased cell growth by activating Akt and Erk1/2 signaling pathways. Our results are the first to indicate that ANXA10 might play an important role in the growth of ESCCs by activating both the Akt andErk1/2 signaling pathways.
In conclusion, our findings revealed that a high expression of ANXA10 is closely correlated with the depth of invasion, high numbers of infiltrating CD68 þ and CD204 þ TAMs and a poor prognosis of ESCC patients. Our findings also demonstrated that ANXA10 promoted the cell growth of ESCC cells via the phosphorylation of Akt and Erk1/2 pathways in vitro. ANXA10 might be a new biomarker and therapeutic target for the progression of ESCC.
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